Chemicals - Specialty
Compare Stocks
2 / 10Stock Comparison
BCPC vs CTVA
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural Inputs
BCPC vs CTVA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals - Specialty | Agricultural Inputs |
| Market Cap | $5.17B | $54.89B |
| Revenue (TTM) | $1.06B | $17.89B |
| Net Income (TTM) | $158M | $1.16B |
| Gross Margin | 36.3% | 33.5% |
| Operating Margin | 21.0% | 13.8% |
| Forward P/E | 31.2x | 22.3x |
| Total Debt | $192M | $2.58B |
| Cash & Equiv. | $75M | $4.52B |
BCPC vs CTVA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Balchem Corporation (BCPC) | 100 | 160.3 | +60.3% |
| Corteva, Inc. (CTVA) | 100 | 299.4 | +199.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BCPC vs CTVA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BCPC carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 8.8%, EPS growth 20.9%, 3Y rev CAGR 3.2%
- 8.8% revenue growth vs CTVA's 2.9%
- 15.0% margin vs CTVA's 6.5%
CTVA is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 5 yrs, beta 0.29, yield 0.9%
- 195.9% 10Y total return vs BCPC's 162.8%
- Lower volatility, beta 0.29, Low D/E 10.6%, current ratio 1.43x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.8% revenue growth vs CTVA's 2.9% | |
| Value | Lower P/E (22.3x vs 31.2x), PEG 1.87 vs 2.44 | |
| Quality / Margins | 15.0% margin vs CTVA's 6.5% | |
| Stability / Safety | Beta 0.29 vs BCPC's 0.33, lower leverage | |
| Dividends | 0.5% yield, 11-year raise streak, vs CTVA's 0.9% | |
| Momentum (1Y) | +32.1% vs BCPC's -0.8% | |
| Efficiency (ROA) | 9.4% ROA vs CTVA's 2.7%, ROIC 12.2% vs 8.5% |
BCPC vs CTVA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BCPC vs CTVA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BCPC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CTVA is the larger business by revenue, generating $17.9B annually — 16.9x BCPC's $1.1B. BCPC is the more profitable business, keeping 15.0% of every revenue dollar as net income compared to CTVA's 6.5%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.1B | $17.9B |
| EBITDAEarnings before interest/tax | $267M | $3.4B |
| Net IncomeAfter-tax profit | $158M | $1.2B |
| Free Cash FlowCash after capex | $182M | $2.1B |
| Gross MarginGross profit ÷ Revenue | +36.3% | +33.5% |
| Operating MarginEBIT ÷ Revenue | +21.0% | +13.8% |
| Net MarginNet income ÷ Revenue | +15.0% | +6.5% |
| FCF MarginFCF ÷ Revenue | +17.2% | +11.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.1% | +11.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +10.6% | +12.6% |
Valuation Metrics
CTVA leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 34.0x trailing earnings, BCPC trades at a 34% valuation discount to CTVA's 51.1x P/E. Adjusting for growth (PEG ratio), BCPC offers better value at 2.65x vs CTVA's 4.28x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $5.2B | $54.9B |
| Enterprise ValueMkt cap + debt − cash | $5.3B | $52.9B |
| Trailing P/EPrice ÷ TTM EPS | 33.97x | 51.10x |
| Forward P/EPrice ÷ next-FY EPS est. | 31.23x | 22.30x |
| PEG RatioP/E ÷ EPS growth rate | 2.65x | 4.28x |
| EV / EBITDAEnterprise value multiple | 20.06x | 13.85x |
| Price / SalesMarket cap ÷ Revenue | 4.98x | 3.15x |
| Price / BookPrice ÷ Book value/share | 4.18x | 2.26x |
| Price / FCFMarket cap ÷ FCF | 29.86x | 19.50x |
Profitability & Efficiency
BCPC leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
BCPC delivers a 12.4% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $5 for CTVA. CTVA carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to BCPC's 0.15x. On the Piotroski fundamental quality scale (0–9), BCPC scores 9/9 vs CTVA's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +12.4% | +4.6% |
| ROA (TTM)Return on assets | +9.4% | +2.7% |
| ROICReturn on invested capital | +12.2% | +8.5% |
| ROCEReturn on capital employed | +14.8% | +8.6% |
| Piotroski ScoreFundamental quality 0–9 | 9 | 6 |
| Debt / EquityFinancial leverage | 0.15x | 0.11x |
| Net DebtTotal debt minus cash | $117M | -$1.9B |
| Cash & Equiv.Liquid assets | $75M | $4.5B |
| Total DebtShort + long-term debt | $192M | $2.6B |
| Interest CoverageEBIT ÷ Interest expense | 15.23x | 5.82x |
Total Returns (Dividends Reinvested)
CTVA leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTVA five years ago would be worth $17,540 today (with dividends reinvested), compared to $12,441 for BCPC. Over the past 12 months, CTVA leads with a +32.1% total return vs BCPC's -0.8%. The 3-year compound annual growth rate (CAGR) favors CTVA at 13.3% vs BCPC's 8.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +4.8% | +20.9% |
| 1-Year ReturnPast 12 months | -0.8% | +32.1% |
| 3-Year ReturnCumulative with dividends | +28.0% | +45.5% |
| 5-Year ReturnCumulative with dividends | +24.4% | +75.4% |
| 10-Year ReturnCumulative with dividends | +162.8% | +195.9% |
| CAGR (3Y)Annualised 3-year return | +8.6% | +13.3% |
Risk & Volatility
CTVA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CTVA is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than BCPC's 0.33 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CTVA currently trades 95.5% from its 52-week high vs BCPC's 87.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.33x | 0.29x |
| 52-Week HighHighest price in past year | $183.90 | $85.63 |
| 52-Week LowLowest price in past year | $139.17 | $60.54 |
| % of 52W HighCurrent price vs 52-week peak | +87.8% | +95.5% |
| RSI (14)Momentum oscillator 0–100 | 32.3 | 64.4 |
| Avg Volume (50D)Average daily shares traded | 189K | 3.4M |
Analyst Outlook
Evenly matched — BCPC and CTVA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates BCPC as "Buy" and CTVA as "Buy". Consensus price targets imply 7.8% upside for CTVA (target: $88) vs 0.4% for BCPC (target: $162). For income investors, CTVA offers the higher dividend yield at 0.86% vs BCPC's 0.54%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $162.00 | $88.17 |
| # AnalystsCovering analysts | 10 | 37 |
| Dividend YieldAnnual dividend ÷ price | +0.5% | +0.9% |
| Dividend StreakConsecutive years of raises | 11 | 5 |
| Dividend / ShareAnnual DPS | $0.87 | $0.71 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.1% | +2.0% |
CTVA leads in 3 of 6 categories (Valuation Metrics, Total Returns). BCPC leads in 2 (Income & Cash Flow, Profitability & Efficiency). 1 tied.
BCPC vs CTVA: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is BCPC or CTVA a better buy right now?
For growth investors, Balchem Corporation (BCPC) is the stronger pick with 8.
8% revenue growth year-over-year, versus 2. 9% for Corteva, Inc. (CTVA). Balchem Corporation (BCPC) offers the better valuation at 34. 0x trailing P/E (31. 2x forward), making it the more compelling value choice. Analysts rate Balchem Corporation (BCPC) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BCPC or CTVA?
On trailing P/E, Balchem Corporation (BCPC) is the cheapest at 34.
0x versus Corteva, Inc. at 51. 1x. On forward P/E, Corteva, Inc. is actually cheaper at 22. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Corteva, Inc. wins at 1. 87x versus Balchem Corporation's 2. 44x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — BCPC or CTVA?
Over the past 5 years, Corteva, Inc.
(CTVA) delivered a total return of +75. 4%, compared to +24. 4% for Balchem Corporation (BCPC). Over 10 years, the gap is even starker: CTVA returned +195. 9% versus BCPC's +162. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BCPC or CTVA?
By beta (market sensitivity over 5 years), Corteva, Inc.
(CTVA) is the lower-risk stock at 0. 29β versus Balchem Corporation's 0. 33β — meaning BCPC is approximately 12% more volatile than CTVA relative to the S&P 500. On balance sheet safety, Corteva, Inc. (CTVA) carries a lower debt/equity ratio of 11% versus 15% for Balchem Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — BCPC or CTVA?
By revenue growth (latest reported year), Balchem Corporation (BCPC) is pulling ahead at 8.
8% versus 2. 9% for Corteva, Inc. (CTVA). On earnings-per-share growth, the picture is similar: Corteva, Inc. grew EPS 23. 1% year-over-year, compared to 20. 9% for Balchem Corporation. Over a 3-year CAGR, BCPC leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BCPC or CTVA?
Balchem Corporation (BCPC) is the more profitable company, earning 14.
9% net margin versus 6. 3% for Corteva, Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCPC leads at 21. 1% versus 15. 1% for CTVA. At the gross margin level — before operating expenses — CTVA leads at 43. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BCPC or CTVA more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Corteva, Inc. (CTVA) is the more undervalued stock at a PEG of 1. 87x versus Balchem Corporation's 2. 44x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Corteva, Inc. (CTVA) trades at 22. 3x forward P/E versus 31. 2x for Balchem Corporation — 8. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CTVA: 7. 8% to $88. 17.
08Which pays a better dividend — BCPC or CTVA?
All stocks in this comparison pay dividends.
Corteva, Inc. (CTVA) offers the highest yield at 0. 9%, versus 0. 5% for Balchem Corporation (BCPC).
09Is BCPC or CTVA better for a retirement portfolio?
For long-horizon retirement investors, Corteva, Inc.
(CTVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 29), 0. 9% yield, +195. 9% 10Y return). Both have compounded well over 10 years (CTVA: +195. 9%, BCPC: +162. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BCPC and CTVA?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.